Followed	Item	Bill Number	Bill Title	Sponsor
	1	H.743	An Act establishing a commission to study a state-wide drug repository program	Bradley H. Jones, Jr.
	2	H.729	An Act to ensure prescription drug cost transparency and affordability	Christine P. Barber
	3	H.1248	An Act relative to provide immediate relief to businesses on health care costs	F. Jay Barrows
	4	H.1254	An Act relative to promoting comprehensive transparency in the pharmaceutical industry	Edward F. Coppinger
	5	H.1257	An Act relative to the treatment of epilepsy and seizure disorders	Michael S. Day
	6	H.1272	An Act to promote transparency in prescription drug prices	Kate Hogan
	7	H.1278	An Act relative to prescription drug price transparency	Bradley H. Jones, Jr.
	8	H.1279	An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth	Bradley H. Jones, Jr.
	9	H.1303	An Act relative to compensation for victims of opioids	James J. O'Day
	10	H.1307	An Act establishing a study to examine the feasibility of state manufactured generic prescription drugs	Smitty Pignatelli
	11	H.1311	An Act relative to step therapy and patient safety	Jeffrey N. Roy
	12	H.3787	An Act relative to pharmacy benefit managers reimbursements to pharmacies in the Commonwealth	Alyson M. Sullivan
	13	S.736	An Act relative to promoting comprehensive transparency in the pharmaceutical industry	Joseph A. Boncore
	14	S.756	An Act relative to step therapy and patient safety	Julian Cyr
	15	S.771	An Act relative to pharmaceutical access, costs and transparency	Cindy F. Friedman
	16	S.785	An Act to improve the accessibility and affordability of pharmaceutical drugs of public health concern	Eric P. Lesser
	17	S.786	An Act to bring down the cost of prescription drugs	Eric P. Lesser
	18	S.790	An Act to define modest meals and refreshments in prescriber education settings	Jason M. Lewis
	19	S.803	An Act relative to coverage for chronic illness	Mark C. Montigny
	20	S.804	An Act to promote transparency and prevent price gouging of pharmaceutical drug prices	Mark C. Montigny
	21	S.808	An Act relative to cancer patient access to biomarker testing to provide appropriate therapy	Susan L. Moran